Patrick O'Brien | Investor Relations |
John Higgins | Chief Executive Officer |
Matt Korenberg | Executive Vice President, Finance and Chief Financial Officer |
Matt Foehr | President and Chief Operating Officer |
Joe Pantginis | H.C. Wainwright |
Balaji Prasad | Barclays |
Matt Hewitt | Craig-Hallum Capital Group |
Scott Henry | Roth Capital |
Dana Flanders | Guggenheim Securities |
Ladies and gentlemen, thank you for standing by, and welcome to the Ligand Pharmaceuticals’ Q4 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. [Operator Instructions] I would now like to hand the conference over to your speaker today, Patrick O'Brien. Thank you.